Effect of Cilostazol as an Antiplatelet Agent on Diabetic Nephropathy with Macroalbuminuria: A Randomized, Double-Blind, Placebo-Controlled Trial (ATP-DN)

Abstract

ISSN: 2574-7568 1 Volume 7; Issue 01 Research Article Effect of Cilostazol as an Antiplatelet Agent on Diabetic Nephropathy with Macroalbuminuria: A Randomized, Double-Blind, Placebo-Controlled Trial (ATP-DN) Naoto Seki1*, Hideo Nishimura2, Sumire Ohtani3, Motonobu Nishimura1, Makoto Ujihara4, Yuji Aoki5, Mikio Shida6, Tsuyoshi Tanaka7, Kensei Yahata8, Hideki Taki9, Kiniko Kawada10, Kazuyuki Hida11, Yoshiaki Oda12, Toshihiko Sumii13, Hideyuki Yoshizumi14, Yojiro Kawabe15, Hidetoshi Kikuchi16, Yoshiharu Hoshiyama17 1National Hospital Organization, Chiba-East National Hospital, Chiba, Japan 2National Hospital Organization, Asahikawa Medical Center, Asahikawa, Japan 3National Hospital Organization, Saitama National Hospital, Wako, Japan 4National Hospital Organization, Yokohama Medical Center, Yokohama, Japan 5National Hospital Organization, Matsumoto Medical Center, Matsumoto Hospital, Matsumoto Japan 6National Hospital Organization, Shizuoka Medical Center, Shizuoka, Japan 7National Hospital Organization, Mie Chuo Medical Center, Mie, Japan 8National Hospital Organization, Kyoto Medical Center, Kyoto, Japan 9National Hospital Organization, Osaka Medical Center, Osaka, Japan 10National Hospital Organization, Hamada Medical Center, Hamada, Japan 11National Hospital Organization, Okayama Medical Center, Okayama, Japan 12National Hospital Organization, Higashihiroshima Medical Center, Higashihiroshima, Japan 13National Hospital Organization, Kokura Medical Center, Kitakyusyu, Japan 14National Hospital Organization, Kusyu Medical Center, Fukuoka, Japan 15National Hospital Organization, Ureshino Medical Center, Ureshino, Japan 16National Hospital Organization, Beppu Medical Center, Beppu, Japan 17School of Nursing, Yokohama Soei University, Kanagawa, Japan